Australia Breaking News

GQG Partners (ASX:GQG) posted a net profit of US$228.4 million for the first half of the financial year.

Perpetual (ASX:PPT) announced it will book a non-cash impairment charge of $63.5 million following a major upcoming client redemption.

AMA Group (ASX:AMA) delivered a record revenue of $1.04 billion for the financial year ended June 30.

Coast Entertainment (ASX:CEH) reported a net profit after tax of $6.1 million for the 53-week financial year ended June 30.

Arena REIT (ASX:ARF) reported a net operating profit of $79.1 million for the full year ended June 30, marking an 8% increase.

Credit Corp Group (ASX:CCP) agreed to buy the HSBC Bank Australia run-off book for $150 million.

Charter Hall Group (ASX:CHC) announced operating earnings of $488.1 million for the 2026 financial year.

Ten Cap co-founder and Lead Portfolio Manager Jun Bei Liu breaks down the difficulty of intervening in the bond market at a time when AI firms are pouring massive capital into capital expenditure.

Gold miner Regis Resources (ASX:RRL) reported a record net profit of $715 million for the year.

DigiCo Infrastructure REIT (ASX:DGT) reported underlying EBITDA of $127 million for the year ended June 30.

Known as India's 'Queen of Biotech', Kiran Mazumdar-Shaw built Biocon from a rented garage almost 50 years ago. Today, her multibillion-dollar company is one of the world's biggest producers of insulin, and a leading force in biosimilars. As she looks at handing over her life's work to successors, Mazumdar-Shaw talks to Bloomberg's Haslinda Amin about her pioneering journey as a female entrepreneur in India, her mission to deliver life-saving therapies to patients and what she believes India must do to tackle an AI future.

Known as India's 'Queen of Biotech', Kiran Mazumdar-Shaw built Biocon from a rented garage almost 50 years ago. Today, her multibillion-dollar company is one of the world's biggest producers of insulin, and a leading force in biosimilars. As she looks at handing over her life's work to successors, Mazumdar-Shaw talks to Bloomberg's Haslinda Amin about her pioneering journey as a female entrepreneur in India, her mission to deliver life-saving therapies to patients and what she believes India must do to tackle an AI future.